Evidence map›Paper›PMID 36225386›Full record

ReviewFrontiers in microbiology2022

Human gut microbiota in health and disease: Unveiling the relationship.

Muhammad Afzaal, Farhan Saeed, Yasir Abbas Shah, Muzzamal Hussain, Roshina Rabail, Claudia Terezia Socol, Abdo Hassoun, Mirian Pateiro, José M Lorenzo, Alexandru Vasile Rusu and 1 more

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 430 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
430citing papers in PubMed, 6 pooled it
49.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

430 citing papers in PubMed, 6 syntheses or guidelines pooled it, 637 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Heat-treatedJournal of microbiology and biotechnology · 2026
    Trial
  8. Trial
  9. Review
  10. Review
  11. Review
  12. Veterinary and animal science · 2026
    Article
  13. Article
  14. Article
  15. Observational
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article

370 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 3 countries.

Muhammad AfzaalDepartment of Food Science, Government College University Faisalabad, Faisalabad, Pakistan.
Farhan SaeedDepartment of Food Science, Government College University Faisalabad, Faisalabad, Pakistan.
Yasir Abbas ShahDepartment of Food Science, Government College University Faisalabad, Faisalabad, Pakistan.
Muzzamal HussainDepartment of Food Science, Government College University Faisalabad, Faisalabad, Pakistan.
Roshina RabailNational Institute of Food Science and Technology, University of Agriculture, Faisalabad, Pakistan.
Claudia Terezia SocolDepartment of Genetics, University of Oradea, Oradea, Romania.
Abdo HassounSustainable AgriFoodtech Innovation & Research (SAFIR), Arras, France.
Mirian PateiroCentro Tecnológico de la Carne de Galicia, Ourense, Spain.
José M LorenzoCentro Tecnológico de la Carne de Galicia, Ourense, Spain.
Alexandru Vasile RusuLife Science Institute, University of Agricultural Sciences and Veterinary Medicine Cluj-Napoca, Cluj-Napoca, Romania.
Rana Muhammad AadilNational Institute of Food Science and Technology, University of Agriculture, Faisalabad, Pakistan.
Government College University, Faisalabad · PKUniversity of Agriculture Faisalabad · PKUniversidade de Vigo · ESUniversity of Agricultural Sciences and Veterinary Medicine of Cluj-Napoca · ROUniversity of Oradea · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The human gut possesses millions of microbes that define a complex microbial community. The gut microbiota has been characterized as a vital organ forming its multidirectional connecting axis with other organs. This gut microbiota axis is responsible for host-microbe interactions and works by communicating with the neural, endocrinal, humoral, immunological, and metabolic pathways. The human gut microorganisms (mostly non-pathogenic) have symbiotic host relationships and are usually associated with the host's immunity to defend against pathogenic invasion. The dysbiosis of the gut microbiota is therefore linked to various human diseases, such as anxiety, depression, hypertension, cardiovascular diseases, obesity, diabetes, inflammatory bowel disease, and cancer. The mechanism leading to the disease development has a crucial correlation with gut microbiota, metabolic products, and host immune response in humans. The understanding of mechanisms over gut microbiota exerts its positive or harmful impacts remains largely undefined. However, many recent clinical studies conducted worldwide are demonstrating the relation of specific microbial species and eubiosis in health and disease. A comprehensive understanding of gut microbiota interactions, its role in health and disease, and recent updates on the subject are the striking topics of the current review. We have also addressed the daunting challenges that must be brought under control to maintain health and treat diseases.

Indexed as

diseasedysbiosiseubiosishealthhuman gut microbiotapathogenic

Identifiers

PMID36225386
PMCPMC9549250
OpenAlexW4297225858

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.